Tyrosine kinase inhibitors are potent and selective inhibitors of UGT1A1: Tools for UGT phenotyping

被引：0
作者：
Kalyanaraman, Nataraj
Li, Chun
Surapaneni, Sekhar S.
Kumar, Gondi N.
机构：
[1] Amgen Inc, PKDM, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept PKDM MS, Newbury Pk, CA USA
[3] Amgen Inc, Dept PKDM MS, Thousand Oaks, CA 91320 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
74
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
[21]   Potent and selective inhibitors of the FGF receptor-1 tyrosine kinase [J].
Westwell, AD .
DRUG DISCOVERY TODAY, 2001, 6 (07) :379-379
[22]   Identification of selective inhibitors of uridine 5'-diphospho-glucuronosyltransferase (UGT) 1A3 and UGT1A8 and their application in UGT reaction phenotyping studies in human liver and intestinal microsomes [J].
Wang, Ting ;
Anderson, Alyssa P. ;
Yu, Andrew S. ;
Taub, Mitchell E. ;
Chan, Tom S. .
DRUG METABOLISM AND DISPOSITION, 2025, 53 (05)
[23]   The Development of UGT1A1 and UGT1A6 in Pediatric Liver [J].
Miyagi, Shogo J. ;
Abby, C. .
DRUG METABOLISM REVIEWS, 2009, 41 :17-18
[24]   Performance of In Silico Tools for the Evaluation of UGT1A1 Missense Variants [J].
Rodrigues, Carina ;
Santos-Silva, Alice ;
Costa, Elisio ;
Bronze-da-Rocha, Elsa .
HUMAN MUTATION, 2015, 36 (12) :1215-1225
[25]   The use of chemical inhibitors in the UGT reaction phenotyping of acetaminophen [J].
Bauman, Jonathan Neal ;
Mutlib, Abdul E. ;
Goosen, Theunis C. .
DRUG METABOLISM REVIEWS, 2006, 38 :46-46
[26]   Inhibition of UGT1A1*1 and UGT1A1*6 catalyzed glucuronidation of SN-38 by silybins [J].
Li, Wei ;
Chen, Yin-Nan ;
Chen, Yue-Yue ;
Wang, Zhe ;
Wang, Zhen ;
Jiang, Li-Li ;
Shi, Hong-Can ;
Liu, Yong .
CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 368
[27]   The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1 [J].
Fujita, Ken-ichi ;
Sugiyama, Minako ;
Akiyama, Yuko ;
Ando, Yuichi ;
Sasaki, Yasutsuna .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) :237-241
[28]   Severe irinotecan-induced toxicity in a patient with UGT1A1*28 and UGT1A1*6 polymorphisms [J].
Xu, Jian-Ming ;
Wang, Yan ;
Ge, Fei-Jiao ;
Lin, Li ;
Liu, Ze-Yuan ;
Sharma, Manish R. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (24) :3899-3903
[29]   The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1 [J].
Ken-ichi Fujita ;
Minako Sugiyama ;
Yuko Akiyama ;
Yuichi Ando ;
Yasutsuna Sasaki .
Cancer Chemotherapy and Pharmacology, 2011, 67 :237-241
[30]   Correlation of bilirubin glucuronidation and estradiol-3-glucuronidation by UGT1A1: studies with model inhibitors [J].
Zhou, Jin ;
Tracy, Timothy S. ;
Remmel, Rory P. .
DRUG METABOLISM REVIEWS, 2009, 41 :43-43
12345